
Venture investor backing food and beverage technology companies, run by finance professionals and former food operators

Life science investor putting money into young oncology and genetic disease drug developers

DROIA Ventures is a specialist investor in early drug development companies. It works worldwide and puts money only into therapies for cancer and genetic disease. Its in-house team of drug developers and biotech professionals takes an active part in the companies it backs, from their creation to clinical proof of concept.
It targets biotech companies whose technology or scientific insight can address clinical problems not solved before. It judges promise by how much a therapy could improve patient outcomes compared with the expected standard of care. Its portfolio spans the US and Europe.
Profile written by TrustList from the business's own published information, Oct 2026.
2 images - click to enlarge
As of 2026-10-10. Organic ranks only; sponsored placements are never ranks.
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about DROIA Ventures.
Similar listings buyers compare against this one.

Venture investor backing food and beverage technology companies, run by finance professionals and former food operators
New York venture capital firm making early and growth stage investments on the East Coast, mostly as co-investor

Healthcare venture firm investing in medical device, pharmaceutical and therapy companies with experienced management teams

New York boutique venture firm investing in growth-stage technology companies across several sectors

Austin-based evergreen venture firm investing in software, technology-enabled and life science companies

Impact-focused venture fund backing scalable businesses that tackle social and environmental problems
Everything here links back to the same verified catalogue. Pick your next stop.